$INDV
Indivior Pharmaceuticals Inc is a holding company, which engages in the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence. Its products include Suboxone Film, Suboxone Tablet, and Subutex Tablet. It operates through the following geographical segments: United States, Rest of World, and United Kingdom. The company was founded on September 26, 2014 and is headquartered in North Chesterfield, VA.
Healthcare
Sector
Drug Manufacturers - Specialty & Generic
Industry
Joseph J. Ciaffoni
CEO
1030
Employees
$31.33
Current Price
$4.29B
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 2 weeks | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 1 month | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 2 months | Buys | 2 | 3 | $31,211.14 | 979 | All Buys |
| Sells | 0 | 0 | - | - | ||
| 3 months | Buys | 2 | 3 | $31,211.14 | 979 | All Buys |
| Sells | 0 | 0 | - | - | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Mar 13, 2026 | Ryan Barbara Director | Purchase | 8 | $31.09 | $248.68 | View Details |
| Mar 6, 2026 | Kingsley Stuart A Director | Purchase | 940 | $31.86 | $29,953.10 | View Details |
| Mar 9, 2026 | Ryan Barbara Director | Purchase | 31 | $32.56 | $1,009.36 | View Details |
5 more transactions available โ create a free account to see 12 months of history | ||||||
Upcoming Earnings
Scheduled earnings reports
EPS
EstimatedN/A
ActualN/A
Revenue
EstimatedN/A
ActualN/A
EPS
Estimated$0.65
ActualN/A
Revenue
Estimated$272.64M
ActualN/A
Past Earnings
Historical earnings results
EPS
Estimated$0.65
ActualN/A
Revenue
Estimated$305.62M
ActualN/A
EPS
Estimated$0.65
ActualN/A
Revenue
EstimatedN/A
ActualN/A
3 more earnings records available โ create a free account to see 12 months of history
Related Activity
Cross-company insider connections and cluster buy signals